CFDA Approves Vildagliptin in Combination with Insulin or Sulfonylureas for Type 2 Diabetes Treatment
May 31, 2018 00:00
CST Updated
00:00
Novartis
Drug Development and Manufacturing
This article is reprinted from: "International Diabetes"
(Translational Medicine Network 360zhyx.com)